Spontaneous factor XI inhibitors. Seven additional cases and a review of the literature
- 1 March 1984
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 144 (3) , 525-529
- https://doi.org/10.1001/archinte.144.3.525
Abstract
Circulating anticoagulants are endogenous blood components that inhibit the action of clotting factors. In some inhibitor conditions this inactivation in the function of the hemostatic system may lead to life-threatening hemorrhagic diathesis. Inhibitors directed against factor XI are generally associated with little or no impairment of the hemostatic system. All reported cases of spontaneous factor XI inhibitor were analyzed in the international literature, as well as other cases identified considering clinical spectrum, diagnosis and therapy.This publication has 12 references indexed in Scilit:
- Incidence of Circulating Anticoagulants in a Normal PopulationActa Haematologica, 1982
- Circulating factor XI antibody and disseminated intravascular coagulationArchives of internal medicine (1960), 1981
- In vitro correction of anticoagulant activity and specific clotting factor assays in SLEThrombosis Research, 1980
- Circulating anticoagulant in the procainamide-induced lupus syndromeArchives of internal medicine (1960), 1977
- Circulating Anticoagulant against Factor XI and Thrombocytopenia with Platelet Aggregation Inhibition in Systemic Lupus ErythematosusActa Haematologica, 1977
- CLINICAL-STUDY OF LUPUS ANTICOAGULANT1976
- Circulating Anticoagulants Against Factors IX and XI in Systemic Lupus ErythematosusAnnals of Internal Medicine, 1972
- A Study of Coagulation Factor Levels in Women during Labour and in Their Newborn InfantsThrombosis and Haemostasis, 1966
- THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS1963
- DEMONSTRATION OF A CIRCULATING ANTICOAGULANT IN PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCYJournal of Clinical Investigation, 1958